It has previously shown that a constitutive activity of the BCR as well as altered cytoskeleton structure is associated with B cell-derived neoplasms, such as the activated B cell subtype of diffuse large B cell lymphoma (DLBCL, ABC) or chronic lymphocytic leukemia (CLL) (52). This evidence concerns the gene BCR and diffuse large B-cell lymphoma.